SS Innovations Appoints Sarah Romano as CFO to Drive Global Expansion and FDA Approval

SS Innovations International (NASDAQ: SSII) appointed Sarah M. Romano as CFO, effective August 3, 2026, to lead financial operations as the company pursues FDA approval for its SSi Mantra surgical robotic system and expands globally.

AI Industry News Staff
Healthcare
SS Innovations Appoints Sarah Romano as CFO to Drive Global Expansion and FDA Approval

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.

SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

The appointment of a seasoned CFO like Romano signals a strategic move to strengthen financial leadership as the company navigates regulatory milestones and global expansion. Her experience in capital raising and financial restructuring could be pivotal in supporting the company’s path to FDA approval and commercial growth. For more information, visit the full press release at https://ibn.fm/pAqlP.

SS Innovations International is listed on NASDAQ under the ticker SSII. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.

Blockchain Registration

QR Code for Blockchain Registration